A cadaveric perfused model with antegrade arteriovenous pulsatile circulation: a new tool for teaching endovascular skills.

Authors:
Rifahi A; Chastant R; Forest-Nault C; Refet-Mollof E; Guy A and 3 more

Journal:
Can J Surg

Publication Year: 2022

DOI:
10.1503/cjs.023020

PMCID:
PMC9337867

PMID:
35790239

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Can J Surg

Abbreviation: Can J Surg

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: General Surgery

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Strategies to reduce out-of-pocket medication costs for Canadians with peripheral arterial disease.
McClure GR; McIntyre WF; Belesiotis P and 10 more (2024) - Transparency Score: 2/6
The impact of public health lockdown measures during the COVID-19 pandemic on the epidemiology of c…
Tarchala M; Bradley CS; Grant S and 4 more (2024) - Transparency Score: 3/6
Total hip arthroplasty with monobloc press-fit acetabular components and large-diameter bearings fo…
Synnott PA; Kiss MO; Shahin M and 3 more (2024) - Transparency Score: 3/6
Trauma resident exposure in Canada and operative numbers (TraumaRECON): a national multicentre retr…
Engels PT; Shi Q; Coates A and 16 more (2024) - Transparency Score: 3/6
2023 Canadian Surgery Forum: Sept. 20-23, 2023.
Brière R; Émond M; Benhamed A and 473 more (2023) - Transparency Score: 1/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Competing interests: Ahmad Rifahi and Elena Refet-Mollof report patents that are broadly relevant to this study. Catherine Forest-Nault and Aymeric Guy are cofounders and co-owners of LifeEngine Technologies, the company that designed this system, and hold the patent for the system. No other competing interests were declared."

Funding Disclosure
Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025